aluates Reports

$ 0.0

Automative

Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-6F13207

BUY CHAPTERS

Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Research Report 2025

Code: QYRE-Auto-6F13207

Report

April 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AGC Biologics

Celonic GmbH

Catalent

Lonza

Patheon

Rentschler Biopharma SE

BlueReg

Bio Elpida

CGT Catapult

Cellipont Bioservices

Minaris Regenerative Medicine

Recipeharm

WuXi Advanced Therapies

Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size

The global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services was valued at US$ 6476 million in the year 2024 and is projected to reach a revised size of US$ 16230 million by 2031, growing at a CAGR of 14.2% during the forecast period.

Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market

Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP’s), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product’s future.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services.

The Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Report

Report Metric	Details
Report Name	Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market
Accounted market size in year	US$ 6476 million
Forecasted market size in 2031	US$ 16230 million
CAGR	14.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gene Therapy Cell Therapy Tissue Engineered Others
Segment by Application	Oncology Cardiology Central Nervous System Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AGC Biologics, BlueReg, Bio Elpida, Celonic, CGT Catapult, Catalent, Cellipont Bioservices, Lonza, Minaris Regenerative Medicine, Patheon, Rentschler Biopharma SE, Recipeharm, WuXi Advanced Therapies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market growing?

Ans: The Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market witnessing a CAGR of 14.2% during the forecast period 2025-2031.

What is the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market size in 2031?

Ans: The Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market size in 2031 will be US$ 16230 million.

Who are the main players in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market report?

Ans: The main players in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market are AGC Biologics, BlueReg, Bio Elpida, Celonic, CGT Catapult, Catalent, Cellipont Bioservices, Lonza, Minaris Regenerative Medicine, Patheon, Rentschler Biopharma SE, Recipeharm, WuXi Advanced Therapies

What are the Application segmentation covered in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market report?

Ans: The Applications covered in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market report are Oncology, Cardiology, Central Nervous System, Others

What are the Type segmentation covered in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market report?

Ans: The Types covered in the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market report are Gene Therapy, Cell Therapy, Tissue Engineered, Others

Recommended Reports

CDMO & CRO Services

Gene, Cell, Biologics

Drug Types CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gene Therapy

1.2.3 Cell Therapy

1.2.4 Tissue Engineered

1.2.5 Others

1.3 Market by Application

1.3.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Central Nervous System

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Perspective (2020-2031)

2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Growth Trends by Region

2.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Region (2020-2025)

2.2.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Region (2026-2031)

2.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Dynamics

2.3.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Trends

2.3.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Drivers

2.3.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Challenges

2.3.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Revenue

3.1.1 Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Revenue (2020-2025)

3.1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Players (2020-2025)

3.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue

3.4 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Concentration Ratio

3.4.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue in 2024

3.5 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Head office and Area Served

3.6 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Product and Application

3.7 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Breakdown Data by Type

4.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Type (2020-2025)

4.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Type (2026-2031)

5 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Breakdown Data by Application

5.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Application (2020-2025)

5.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)

6.2 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)

6.4 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)

7.2 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)

7.4 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)

8.2 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)

9.2 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)

9.4 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)

10.2 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AGC Biologics

11.1.1 AGC Biologics Company Details

11.1.2 AGC Biologics Business Overview

11.1.3 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.1.4 AGC Biologics Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.1.5 AGC Biologics Recent Development

11.2 BlueReg

11.2.1 BlueReg Company Details

11.2.2 BlueReg Business Overview

11.2.3 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.2.4 BlueReg Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.2.5 BlueReg Recent Development

11.3 Bio Elpida

11.3.1 Bio Elpida Company Details

11.3.2 Bio Elpida Business Overview

11.3.3 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.3.4 Bio Elpida Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.3.5 Bio Elpida Recent Development

11.4 Celonic

11.4.1 Celonic Company Details

11.4.2 Celonic Business Overview

11.4.3 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.4.4 Celonic Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.4.5 Celonic Recent Development

11.5 CGT Catapult

11.5.1 CGT Catapult Company Details

11.5.2 CGT Catapult Business Overview

11.5.3 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.5.4 CGT Catapult Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.5.5 CGT Catapult Recent Development

11.6 Catalent

11.6.1 Catalent Company Details

11.6.2 Catalent Business Overview

11.6.3 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.6.4 Catalent Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.6.5 Catalent Recent Development

11.7 Cellipont Bioservices

11.7.1 Cellipont Bioservices Company Details

11.7.2 Cellipont Bioservices Business Overview

11.7.3 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.7.4 Cellipont Bioservices Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.7.5 Cellipont Bioservices Recent Development

11.8 Lonza

11.8.1 Lonza Company Details

11.8.2 Lonza Business Overview

11.8.3 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.8.4 Lonza Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.8.5 Lonza Recent Development

11.9 Minaris Regenerative Medicine

11.9.1 Minaris Regenerative Medicine Company Details

11.9.2 Minaris Regenerative Medicine Business Overview

11.9.3 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.9.4 Minaris Regenerative Medicine Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.9.5 Minaris Regenerative Medicine Recent Development

11.10 Patheon

11.10.1 Patheon Company Details

11.10.2 Patheon Business Overview

11.10.3 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.10.4 Patheon Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.10.5 Patheon Recent Development

11.11 Rentschler Biopharma SE

11.11.1 Rentschler Biopharma SE Company Details

11.11.2 Rentschler Biopharma SE Business Overview

11.11.3 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.11.4 Rentschler Biopharma SE Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.11.5 Rentschler Biopharma SE Recent Development

11.12 Recipeharm

11.12.1 Recipeharm Company Details

11.12.2 Recipeharm Business Overview

11.12.3 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.12.4 Recipeharm Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.12.5 Recipeharm Recent Development

11.13 WuXi Advanced Therapies

11.13.1 WuXi Advanced Therapies Company Details

11.13.2 WuXi Advanced Therapies Business Overview

11.13.3 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction

11.13.4 WuXi Advanced Therapies Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

11.13.5 WuXi Advanced Therapies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AGC Biologics

Celonic GmbH

Catalent

Lonza

Patheon

Rentschler Biopharma SE

BlueReg

Bio Elpida

CGT Catapult

Cellipont Bioservices

Minaris Regenerative Medicine

Recipeharm

WuXi Advanced Therapies

List of Tables

Table 1. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gene Therapy

Table 3. Key Players of Cell Therapy

Table 4. Key Players of Tissue Engineered

Table 5. Key Players of Others

Table 6. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Region (2020-2025)

Table 10. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Region (2026-2031)

Table 12. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Trends

Table 13. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Drivers

Table 14. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Challenges

Table 15. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints

Table 16. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Players (2020-2025)

Table 18. Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services as of 2024)

Table 19. Ranking of Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Headquarters and Area Served

Table 22. Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Product and Application

Table 23. Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Type (2020-2025)

Table 27. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Type (2026-2031)

Table 29. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Application (2020-2025)

Table 31. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Application (2026-2031)

Table 33. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031) & (US$ Million)

Table 48. AGC Biologics Company Details

Table 49. AGC Biologics Business Overview

Table 50. AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 51. AGC Biologics Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 52. AGC Biologics Recent Development

Table 53. BlueReg Company Details

Table 54. BlueReg Business Overview

Table 55. BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 56. BlueReg Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 57. BlueReg Recent Development

Table 58. Bio Elpida Company Details

Table 59. Bio Elpida Business Overview

Table 60. Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 61. Bio Elpida Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 62. Bio Elpida Recent Development

Table 63. Celonic Company Details

Table 64. Celonic Business Overview

Table 65. Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 66. Celonic Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 67. Celonic Recent Development

Table 68. CGT Catapult Company Details

Table 69. CGT Catapult Business Overview

Table 70. CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 71. CGT Catapult Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 72. CGT Catapult Recent Development

Table 73. Catalent Company Details

Table 74. Catalent Business Overview

Table 75. Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 76. Catalent Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 77. Catalent Recent Development

Table 78. Cellipont Bioservices Company Details

Table 79. Cellipont Bioservices Business Overview

Table 80. Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 81. Cellipont Bioservices Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 82. Cellipont Bioservices Recent Development

Table 83. Lonza Company Details

Table 84. Lonza Business Overview

Table 85. Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 86. Lonza Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 87. Lonza Recent Development

Table 88. Minaris Regenerative Medicine Company Details

Table 89. Minaris Regenerative Medicine Business Overview

Table 90. Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 91. Minaris Regenerative Medicine Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 92. Minaris Regenerative Medicine Recent Development

Table 93. Patheon Company Details

Table 94. Patheon Business Overview

Table 95. Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 96. Patheon Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 97. Patheon Recent Development

Table 98. Rentschler Biopharma SE Company Details

Table 99. Rentschler Biopharma SE Business Overview

Table 100. Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 101. Rentschler Biopharma SE Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 102. Rentschler Biopharma SE Recent Development

Table 103. Recipeharm Company Details

Table 104. Recipeharm Business Overview

Table 105. Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 106. Recipeharm Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 107. Recipeharm Recent Development

Table 108. WuXi Advanced Therapies Company Details

Table 109. WuXi Advanced Therapies Business Overview

Table 110. WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product

Table 111. WuXi Advanced Therapies Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025) & (US$ Million)

Table 112. WuXi Advanced Therapies Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Picture

Figure 2. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Type: 2024 VS 2031

Figure 4. Gene Therapy Features

Figure 5. Cell Therapy Features

Figure 6. Tissue Engineered Features

Figure 7. Others Features

Figure 8. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Application: 2024 VS 2031

Figure 10. Oncology Case Studies

Figure 11. Cardiology Case Studies

Figure 12. Central Nervous System Case Studies

Figure 13. Others Case Studies

Figure 14. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Report Years Considered

Figure 15. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Region: 2024 VS 2031

Figure 18. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Players in 2024

Figure 19. Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue in 2024

Figure 21. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Country (2020-2031)

Figure 23. United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Country (2020-2031)

Figure 27. Germany Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Region (2020-2031)

Figure 35. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Country (2020-2031)

Figure 43. Mexico Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Country (2020-2031)

Figure 47. Turkey Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. AGC Biologics Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 51. BlueReg Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 52. Bio Elpida Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 53. Celonic Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 54. CGT Catapult Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 55. Catalent Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 56. Cellipont Bioservices Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 57. Lonza Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 58. Minaris Regenerative Medicine Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 59. Patheon Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 60. Rentschler Biopharma SE Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 61. Recipeharm Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 62. WuXi Advanced Therapies Revenue Growth Rate in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350